Daxor SG&A Expenses 2010-2011 | DXR
Daxor sg&a expenses from 2010 to 2011. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| Daxor Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2011 | $4 |
| 2010 | $3 |
| 2009 | $3 |
| Daxor Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2011-12-31 | $0 |
| 2011-09-30 | $1 |
| 2011-06-30 | $1 |
| 2011-03-31 | $2 |
| 2010-12-31 | $1 |
| 2010-09-30 | $1 |
| 2010-06-30 | $1 |
| 2010-03-31 | $1 |
| 2009-12-31 | $1 |
| 2009-09-30 | $1 |
| 2009-06-30 | $1 |
| 2009-03-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED-OUTP/HM CRE | $0.036B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | US | $19.866B | 19.58 |
| Encompass Health (EHC) | US | $11.757B | 24.92 |
| DaVita (DVA) | US | $10.848B | 14.40 |
| Chemed (CHE) | US | $8.419B | 26.46 |
| Option Care Health (OPCH) | US | $5.395B | 24.05 |
| Elanco Animal Health (ELAN) | US | $4.840B | 10.71 |
| RadNet (RDNT) | US | $4.004B | 84.73 |
| Amedisys (AMED) | US | $3.151B | 21.19 |
| LifeStance Health (LFST) | US | $2.644B | 0.00 |
| Addus HomeCare (ADUS) | US | $1.932B | 22.10 |
| Astrana Health (ASTH) | US | $1.822B | 36.51 |
| U.S Physical Therapy (USPH) | US | $1.099B | 28.03 |
| Aveanna Healthcare Holdings (AVAH) | US | $0.944B | 0.00 |
| Pennant (PNTG) | US | $0.927B | 37.07 |
| Atai Life Sciences (ATAI) | DE | $0.300B | 0.00 |
| Ontrak (OTRK) | US | $0.006B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | JP | $0.005B | 0.00 |
| Psychemedics (PMD) | US | $0.000B | 0.00 |